Research & Development: Flexible, multi-channel synthesizers ideal for high-throughput oligo synthesis in discovery and validation stages.
Drug Development: Mid-to-large channel systems designed for scale-up, method transfer, and GMP-readiness.
Commercial Manufacturing: High-capacity platforms for industrial oligo production with consistent quality control.
Research & Development: Flexible, multi-channel synthesizers ideal for high-throughput oligo synthesis in discovery and validation stages.
Drug Development: Mid-to-large channel systems designed for scale-up, method transfer, and GMP-readiness.
Commercial Manufacturing: High-capacity platforms for industrial oligo production with consistent quality control.
Research & Development: Flexible, multi-channel synthesizers ideal for high-throughput oligo synthesis in discovery and validation stages.
Drug Development: Mid-to-large channel systems designed for scale-up, method transfer, and GMP-readiness.
Commercial Manufacturing: High-capacity platforms for industrial oligo production with consistent quality control.
Research & Development: Flexible, multi-channel synthesizers ideal for high-throughput oligo synthesis in discovery and validation stages.
Drug Development: Mid-to-large channel systems designed for scale-up, method transfer, and GMP-readiness.
Commercial Manufacturing: High-capacity platforms for industrial oligo production with consistent quality control.
Research & Development: Flexible, multi-channel synthesizers ideal for high-throughput oligo synthesis in discovery and validation stages.
Drug Development: Mid-to-large channel systems designed for scale-up, method transfer, and GMP-readiness.
Commercial Manufacturing: High-capacity platforms for industrial oligo production with consistent quality control.
Our HL Series synthesizer is purpose-built for nucleic acid drug manufacturing, delivering single-channel scales up to 12 mmol with crude product purity exceeding 85%. This ensures high efficiency for downstream purification and shortens the time-to-market for therapeutic oligos.
Designed for post-synthesis processing, enabling efficient cleavage, deprotection, and purification of oligonucleotides with high recovery rates and minimal degradation.
Integrated systems for automated reagent handling, column management, and process control, reducing manual operations and ensuring reproducibility across batches.
From synthesis to post-processing and automation.
From nmol-scale screening to mmol-scale GMP manufacturing.
Supports a wide range of chemical modifications for research and therapeutic needs.
All instruments are optimized to work with Tsingke’s in-house reagents for maximum quality and supply chain security.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
